• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Modern Partnerships with CROs

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    INCOG BioPharma Services

    TaiMed Biologics

    AMERIPHARMA

    CMC Pharmaceuticals

    Societal CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    INCOG BioPharma Services

    TaiMed Biologics

    AMERIPHARMA

    CMC Pharmaceuticals

    Societal CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Creating a Secondary Packaging Strategy

    When is the ideal time to start?

    Creating a Secondary Packaging Strategy
    Ingo Schraut, Product & Service Manager, Vetter Pharma International GmbH03.04.20
    In his book, The 7 Habits of Highly Effective People, the author Dr. Steven R. Covey emphasizes beginning with ‘the end mind.’ This means beginning each day, task, or project with a clear vision of your desired direction and destination, and then continuing to flex your proactive muscle to make things happen. In today’s pharmaceutical market, when it comes to secondary packaging, these words have equal significance.

    Pharmaceutical and biotechnology companies with a drug product in clinical phase III are usually focused on manufacturing scale-up while secondary packaging often doesn’t get the serious attention it needs. Correlations with secondary packaging that are not considered in this phase can have a negative effect on further processability, the variability of the forms of presentation, or on cost and time-to-market. Therefore, starting early to discuss the secondary packaging strategy can save you time and money.

    From our experience as a globally leading contract development and manufacturing organization (CDMO) we would like to demonstrate some of those correlations and give you some food for thought. And so, when does one begin creating a strategy for secondary packaging?

    The impact of primary packaging
    The best starting point is usually when discussing the primary packaging. Without question, the choice of primary packaging has a strong impact on downstream secondary packaging. Consider, for example, the combining of a syringe with an autoinjector or safety device. The format and dimensions of the syringe as well as the barrel flange need to fit to the respective system.

    Additionally, the assembly machine needs to be able to process the combined format parts and it should be certain that the syringe is designed to resist higher mechanical forces. Whenever a drug is launched in an autoinjector, it is set up on an existing platform that usually needs customization and usability studies. Allowing for extra time for device customization will help to achieve a realistic timeline.

    Specific indication and market requirements
    Planning for the best possible solution requires a focus on the administration use case. User, use context and the route of administration can influence requirements of secondary packaging. Consider the handling of ophthalmic syringes utilized in a professional setting. Intra-ocular administration is an action that needs fine motor skills and differs significantly from syringes used for home use, e.g. for arthritis. Consider too, that age and educational levels also have an impact on drug administration.

    Differing country/market specifics can demand extra time that needs to be considered. For example, you must allow extra time for the creation and internal approval of artwork required for multi-country/market labels and booklets. The reimbursement landscape can have an impact on your market approach and market acceptance of your secondary packaging solution. This can be true for doctors, medical professionals, payers and for patients.

    For instance, one could imagine that health insurance companies prefer an autoinjector over a vial kit as the patient can administer it at home and, therefore, saves professional administration costs. Doctors, on the other hand, might prefer the professional administration because they want to monitor their patients, e.g. after injecting an oncology drug. In some countries like the U.S. and Germany, doctors may also prefer a vial kit over an autoinjector because there are more application steps involved and each of them is reimbursed.

    Challenges from regulatory authorities
    Additional market approval demands and extended documentation for more sophisticated solutions such as autoinjectors can influence a product’s time to market. We often encounter customers that plan to launch several variants such as a syringe and autoinjector at the same time. They often end up with a staggered market launch where the simpler variant is approved first and the more sophisticated one follows with delay.

    Country specific regulatory requirements such as additional labels or mandatory variable data can place demands for extra space on the packaging itself. Given differing country and packaging variants, a big batch size in filling often melts down into much smaller country specific secondary packaging production orders. A dedicated launch and supply chain strategy will assure the most expeditious time-to-market.

    Market differentiation
    Secondary packaging gives you the chance to differentiate your product against competition. When done in the best way, differentiation in secondary packaging is focused on the use case and the user needs—such as those already mentioned in the specific indication requirements section. When solving user specific needs, like limited fine motor skills, with a packaging that is easy to open and a device that allows correct administration despite the motoric limits of the users, your product’s marketing opportunities rise. Enhanced functionality and higher convenience often support a product’s safety by ensuring a safer administration and avoiding user errors. Even adherence can be positively affected when administration is easier, less painful or simply done quicker.

    Enhanced functionality and convenience might also be part of a dedicated product lifecycle strategy that evolves over time. Not delivering the full potential with the first market presentation might be worth considering, especially if time to market is crucial.

    Volume scale-up
    Demands and related production order sizes for secondary packaging expand significantly from clinical to commercial. Expect that your partner or in-house production unit is experienced and flexible enough to handle your needs from small-scale to large-scale production with stringent quality. A scalable production setup with a high grade of automation that can cover anticipated changes in a product’s demand helps to ensure quality and reliability. Also, it is very helpful to have a supply chain that is capable of reliably delivering the same quality at whatever quantity. Decent in-house engineering and tooling skills support you when existing equipment needs to be adjusted, and they provide extraordinary support in case of errors. A proven track record in qualifying and establishing solid processes rounds off the skill set that facilitates a dependable supply security.

    Future trends
    Several factors drive the smart monitoring demand for pharmaceuticals. Authority’s demands for commercial products are rising. The FDA emphasizes real-word evidence of efficacy. EMA’s post-market surveillance demands are rising to monitor a product’s safety. Payers and pharmacy benefit managers want to be sure that medication is beneficial, that patients are taking their medications as prescribed and that they work.

    Depending on the region, pay for performance is becoming more popular, especially for expensive treatments. Collected data provide the chance for a deeper understanding of diseases and patient behavior, which is highly interesting for medical professionals, pharma companies and payers. Digital enabled technologies like smart labels and connected devices will evidently play a significant role in the future.

    Since the issue of sustainability became a megatrend, it is gaining traction within the pharmaceutical industry. Big pharma companies discovered this topic as a good fit within their CSR (Corporate Social Responsibility) strategy. Novartis, for example, wants to be “completely plastic neutral, with all new products meeting sustainable design principles*” in 2030.

    Conclusion
    Starting early to discuss secondary packaging aspects can help you optimize manufacturing and stay flexible for upcoming demands. A holistic view supports your goal for a best possible interaction between primary packaging, secondary packaging and production while targeting a user centric solution. The resulting reliability and optimized machineability of your product have a positive effect on costs and time-to-market.

    Such a holistic view requires a broad expertise and an early involvement of all stakeholders, whether they are internal departments or external partners. An experienced partner with broad expertise in dealing with complex packaging solutions and a proven track record for various packaging formats can be a crucial competitive advantage. 

    *https://www.novartis.com/our-company/corporate-responsibility/environmental-sustainability/waste, Abruf 04.09.2019
    Related Searches
    • Development
    • equipment
    • marketing
    • scale-up
      Loading, Please Wait..
      Breaking News
      • Univercells Expands into the U.S. With New Offices in Andover, MA
      • Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
      • Ionis, Roche Partner on RNA-targeted Programs for AD and HD
      • Sanner Group Opens Second Manufacturing Facility in China
      • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
      View Breaking News >
      CURRENT ISSUE

      September 2023

      • Pharma Supply Chains: From Fragile to Agile
      • Overcoming Stressors in Knowledge Transfer
      • Innovations in Pharma Packaging
      • HPAPI Manufacturing Trends
      • Sustainable Packaging in Pharma: No Longer a Pipe Dream
      • Revolutionizing Pharma’s Supply Chain
      • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
      • Solving Pharma’s Underlying Rebate Leakage Problem
      • Advanced Manufacturing and a Roadmap to the Facility of the Future
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
      Natrol Launches First Non-Melatonin Sleep Supplement
      Metagenics Releases Consumer Survey on Menopausal Support Supplement
      Coatings World

      Latest Breaking News From Coatings World

      California Sports Surfaces Celebrates 70 Years
      ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
      AkzoNobel Shares Sustainable Architectural Solutions at Conference
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Dentsply Sirona Names Former NuVasive CEO Lucier as Chairman
      SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
      ResMed, Nyxoah Team Up to Grow Sleep Apnea Awareness & Therapy in Germany
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Univercells Expands into the U.S. With New Offices in Andover, MA
      Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
      Ionis, Roche Partner on RNA-targeted Programs for AD and HD
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
      74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
      Stoelzle Glass Group Names New CEO
      Happi

      Latest Breaking News From Happi

      The Estée Lauder Companies Launches 2023 Breast Cancer Campaign
      BASF Personal Care Introduces New Cosmetic Ingredient
      Breakfast with Oral Care Benefits?
      Ink World

      Latest Breaking News From Ink World

      Siegwerk’s Climate Targets Validated by SBTi
      ROSS Offering Cost-Effective, Expertly Reconditioned Equipment
      Amcor plc Adds Lucrèce Foufopoulos-De Ridder to Board of Directors
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      SABIC and partners launch bio-based IML solution for food packaging
      tesa completes expansion of Michigan manufacturing facility
      Comexi and Asahi to host 'Effortless Platemaking' event
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Greentech Introduces Air Filter with Advanced Odor Elimination
      Ontex Divests Pakistan Operations to ASAIA Holding
      Goodnites Bedwetting Underwear Recognized by Good Housekeeping
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
      ChitogenX Granted New U.S., Canadian ORTHO-R Patent
      Centinel Spine prodisc System Surpasses 2,500-Implant Milestone
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
      Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More
      SCHOTT Strengthens Glass Substrate Portfolio

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login